Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Complete Summary

GUIDELINE TITLE

Massachusetts Department of Mental Retardation health screening recommendations.

BIBLIOGRAPHIC SOURCE(S)

  • Massachusetts Department of Developmental Services. Massachusetts Department of Mental Retardation health screening recommendations. Boston (MA): Massachusetts Department of Developmental Services; 2007. 2 p.

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Massachusetts Department of Mental Retardation, Univ of Massachusetts Medical School's Center for Developmental Disabilities Evaluation and Research. Preventive health recommendations for adults with mental retardation. Boston (MA): Massachusetts Department of Mental Retardation and University of Massachusetts Medical School's Center for Developmental Disabilities Evaluation and Research; 2003 Sep 19. 2 p.

COMPLETE SUMMARY CONTENT

 
SCOPE
 METHODOLOGY - including Rating Scheme and Cost Analysis
 RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 BENEFITS/HARMS OF IMPLEMENTING THE GUIDELINE RECOMMENDATIONS
 QUALIFYING STATEMENTS
 IMPLEMENTATION OF THE GUIDELINE
 INSTITUTE OF MEDICINE (IOM) NATIONAL HEALTHCARE QUALITY REPORT CATEGORIES
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

SCOPE

DISEASE/CONDITION(S)

  • Intellectual disability, learning disability, mental retardation, including Down syndrome
  • Cancer (breast, cervical, colorectal, testicular, prostate, and skin)
  • Infectious diseases (sexually transmitted diseases, human immunodeficiency virus [HIV], hepatitis A, B, and C, tuberculosis, influenza, pneumonia, tetanus, diphtheria, pertussis, measles, mumps, rubella, human papillomavirus infection, varicella, shingles)
  • Hypertension
  • Hypercholesterolemia
  • Diabetes
  • Dysphagia and aspiration
  • Cardiovascular disease
  • Osteoporosis
  • Hearing and vision impairments
  • Glaucoma
  • Depression
  • Dementia

GUIDELINE CATEGORY

Prevention
Screening

CLINICAL SPECIALTY

Family Practice
Internal Medicine
Preventive Medicine

INTENDED USERS

Health Care Providers
Patients
Physician Assistants
Physicians

GUIDELINE OBJECTIVE(S)

To present preventive health recommendations for adults with intellectual or developmental disability (mental retardation)

TARGET POPULATION

Adults (>19 years of age) with intellectual or developmental disability (mental retardation)

INTERVENTIONS AND PRACTICES CONSIDERED

Screening

Cancer Screening

  1. Breast mammography with clinical breast exam as appropriate
  2. Pelvic examination and pap smear
  3. Fecal occult blood testing (FOBT)
  4. Sigmoidoscopy
  5. Colonoscopy
  6. Clinical testicular examination
  7. Digital rectal exam (DRE)
  8. Prostate specific antigen (PSA)
  9. Skin examination

Other Screening

  1. Body mass index (BMI)
  2. Blood pressure
  3. Blood lipid levels
  4. Blood glucose levels
  5. Liver function tests
  6. Dysphagia and aspiration screening
  7. Cardiovascular disease screening
  8. Bone mineral density (BMD)

Infectious Disease Screening

  1. Chlamydia and gonorrhea screening
  2. Human immunodeficiency virus (HIV) screening
  3. Hepatitis B and C screening
  4. Tuberculin skin testing

Sensory Screening

  1. Hearing exam
  2. Vision exam
  3. Eye exam for glaucoma

Mental and Behavioral Health Screening

  1. Depression assessment
  2. Dementia assessment

Screening for Persons with Down Syndrome

  1. Thyroid function test
  2. Cervical spine x-ray
  3. Echocardiogram

Prevention

  1. Health maintenance visit
  2. Oral health visit
  3. Immunizations for:
    • Influenza
    • Pneumococcal pneumonia
    • Hepatitis B and A
    • Tetanus, diphtheria, pertussis (TdaP)
    • Measles, mumps, and rubella (MMR)
    • Human papillomavirus (HPV) infection
    • Varicella
    • Zoster virus infection (shingles)
  4. General counseling and guidance

MAJOR OUTCOMES CONSIDERED

Not stated

METHODOLOGY

METHODS USED TO COLLECT/SELECT EVIDENCE

Searches of Electronic Databases

DESCRIPTION OF METHODS USED TO COLLECT/SELECT THE EVIDENCE

Comprehensive review of available Medline/PubMed sources, comparison to general population screening measures (Massachusetts Quality Health Partnerships), materials developed by advocacy and state agencies

NUMBER OF SOURCE DOCUMENTS

Not stated

METHODS USED TO ASSESS THE QUALITY AND STRENGTH OF THE EVIDENCE

Expert Consensus (Committee)

RATING SCHEME FOR THE STRENGTH OF THE EVIDENCE

Not applicable

METHODS USED TO ANALYZE THE EVIDENCE

Review

DESCRIPTION OF THE METHODS USED TO ANALYZE THE EVIDENCE

Literature review using structured evaluation of strength of evidence. Consensus review with expert clinical panel (see "Description of Methods Used to Formulate the Recommendations" field)

METHODS USED TO FORMULATE THE RECOMMENDATIONS

Expert Consensus

DESCRIPTION OF METHODS USED TO FORMULATE THE RECOMMENDATIONS

The development of the recommendations required careful consideration of many elements in the lives of adults with mental retardation.

Phase I

Committee members received a package of reference material for review prior to the initial meeting. Members reviewed the general findings from the literature search and discussed their own professional experience in community care for people with mental retardation. Following discussion, committee members agreed to adopt generally accepted Massachusetts Health Quality Partners (MHQP) guidelines for the general population as a baseline and develop recommendations for modifications to address areas of greater concern for the population of people with mental retardation.

Based on findings in the literature and the experience of committee members, three focus areas emerged:

  1. The need to review and modify generic MHQP standards to ensure they are appropriate to the health needs of the adult population with intellectual disability.
  2. The need to facilitate effective communication relating to an individual's health, lifestyle, adaptive functioning, and service plan between residential staff or family members and the community clinician.
  3. The need to consider additional recommendations for sub-populations such as those with identifiable syndromes or comorbid conditions that are associated with additional health risks.

The committee formed three sub-groups and each group was charged with developing recommendations to address one of the above areas.

Phase II

Subcommittees met to develop recommendations that were shared at a second Advisory Committee meeting. The entire Advisory Committee reviewed and commented on the work of each subcommittee. The subcommittees then formed their final recommendations.

Phase III

The final meeting and discussion of the Advisory Committee was held for discussion of the remaining work of each committee. Subcommittee members agreed to complete recommendations for the final report to be forwarded to the Department of Mental of Retardation (name changed to Department of Developmental Services as of July 1, 2009).

These recommendations were revised in October 2005 and July 2007.

RATING SCHEME FOR THE STRENGTH OF THE RECOMMENDATIONS

Not applicable

COST ANALYSIS

A formal cost analysis was not performed and published cost analyses were not reviewed.

METHOD OF GUIDELINE VALIDATION

Peer Review

DESCRIPTION OF METHOD OF GUIDELINE VALIDATION

Not stated

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Note: Items that are indicated in Bold Italic are specific recommendations that differ from the Massachusetts Health Quality Partnership (MHQP) recommendations in order to reflect particular health concerns of the population with intellectual disabilities.

Procedure 19-29 Years 30-39 Years 40-49 Years 50-64 Years 65 Years +
Health Maintenance Visit Annually for all ages. Includes initial/interval history, age-appropriate physical exam; height and weight measurements; preventive screenings and counseling; assessment and administration of needed immunizations.
Oral Health Visit Promote dental health through regular oral hygiene practices, assessment by a dentist at least every 6 months, and timely management of dental disease.
Labs and Screenings
Cancer Screening
Breast Cancer: Mammography Clinical breast exam as appropriate. Mammography not routine except for patients at high risk. Accurate and detailed history and family history will identify risk factors. Clinical breast exam as appropriate. Annual mammography at discretion of clinician/patient. Clinical breast exam as appropriate. Annual mammography. Mammography annually through age 69. Age 70+ at discretion of clinician/patient.
Cervical Cancer (Pelvic Exam & Pap Smear) First pap smear by age 21. Every 1-3 years, at clinician/patient's discretion. May be omitted after age 65 if previous screenings were consistently normal.
Colorectal Cancer Not routine except for patients at high risk. Starting at age 50, fecal occult blood testing (FOBT) and sigmoidoscopy every 5 years OR annual FOBT OR colonoscopy every 10 years. Screening after age 80 at clinician/patient discretion.
Testicular and Prostate Cancer Prostate cancer screening not routine. Clinical testicular exam at clinician's discretion. Digital rectal exam (DRE) for patients with risk factors for prostate cancer: family history & African-American ancestry. Prostate specific antigen (PSA) screening in high-risk patients at clinician/patient discretion. DRE. Discuss risks and benefits of PSA blood test with patients starting at age 50. Offer PSA at clinician/patient's discretion.
Skin Cancer Periodic total skin examinations every 3 years between the ages of 20 and 39 and annually at age 40 and older, regardless of skin tone and color. Frequency at clinician discretion based on risk factors.
Other Recommended Screening
Body Mass Index (BMI) Screen for overweight and eating disorders. Consult the Centers for Disease Control and Prevention's (CDC's) growth and BMI charts (www.cdc.gov/nccdphp/dnpa/bmi/index.htm). Ask about body image and diet patterns. Counsel on benefits of physical activity and a healthy diet to maintain desirable weight for height. Offer more focused evaluation and intensive counseling for adults for BMI >30 kg/m2 to promote sustained weight loss.
Hypertension At every acute/non-acute medical encounter and at least annually.
Cholesterol Every five years or at clinician's discretion. At clinician's discretion.
Diabetes (Type 2) At least every 5 years until age 45. Every 3 years after age 45. Fasting plasma glucose screen for individuals at high risk. Risk factors include: family history of premature coronary heart disease (CHD), hypertension, overweight, diabetes mellitus, peripheral atherosclerosis or carotid artery disease, current cigarette smoking, or high-density lipoprotein (HDL) <35 mg/dL.
Liver Function Annually for hepatitis B carriers. At clinician's discretion after consideration of risk factors including long term prescription medication.
Dysphagia & Aspiration Chronic dysphagia and gastroesophageal reflux disease (GERD) are common in individuals with developmental disabilities (DD) and neuromuscular dysfunction. Screen initially and inquire about changes at annual physical.
Cardiovascular Disease Screen for cardiovascular diseases and malformations earlier and more regularly than the general population. Specific syndromes and neuroleptic medications may increase risk for cardiac disease.
Osteoporosis Bone density screening (BMD) starting at age 19 when risk factors are present: long term polypharmacy, mobility impairments, hypothyroid, post-menopausal women. Periodicity of screening at clinician's discretion. Annually counsel about preventive measures including dietary calcium and vitamin D intake, weight-bearing exercise, and smoking cessation. Provide BMD testing. Counsel elderly patients about specific measures to prevent falls.
Infectious Disease Screening
Sexually Transmitted Infections For chlamydia and gonorrhea: Sexually active patients under age 25: Screen annually. Patients age 25 and over: Screen annually, if at risk. Screen pregnant women at the first prenatal visit and in the third trimester, for all sexually transmitted infections (STIs) if at risk.
Human Immunodeficiency Virus (HIV) Periodic testing if at risk and testing of pregnant women at increased risk.
Hepatitis B and C Periodic testing if risk factors present.
Tuberculosis (TB) Tuberculin skin testing ever 1-2 years when risk factors present. Risk factors include residents or employees of congregate setting, close contact with persons known or suspected to have TB.
Sensory Screening
Hearing Assessment Screen annually. Re-evaluate if hearing problem is reported or a change in behavior is noted.
Vision Assessment Screen annually. Re-evaluate if vision problems are reported or change in behavior is noted.
Eye Exam for Glaucoma Every 3-5 years in high risk patients. At least once in patients with no risk factors. Every 2-4 years Every 2-4 years Every 1-2 years
Mental and Behavioral Health
Depression Screen annually for sleep, appetite disturbance, weight loss, general agitation.
Dementia Monitor for problems performing daily activities. In persons with Down Syndrome, annual screen after age 40.
Immunizations
Influenza Annually Annually Annually Annually Annually
Pneumococcal Once, especially if at elevated risk. Once after 65 years of age, even if vaccinated before 65 years of age.
Hepatitis B Once. Reevaluate antibody status every 5 years.
Hepatitis A If at high risk and not previously immunized.
Tetanus, Diphtheria, Pertussis (TdaP) 3 doses if not previously immunized. Booster every 10 years.
Measles, Mumps, and Rubella (MMR) If born after 1956 and have not been immunized or have laboratory evidence of immunity. Receive a second dose of measles-containing vaccine if at risk. Ages 50+: Not routine.
Human Papillomavirus (HPV) Vaccine** Three injections given over a 6-month period to females up to 26 years old.
Varicella (Chicken Pox) 2 doses recommended for those who do not have documentation of age-appropriate immunization or a reliable history of chicken pox (varicella).
Zoster (shingles) Vaccine**   Once after age 60, not for those with weak immune systems.
For Persons with Down Syndrome (in addition to the above recommendations)
Thyroid Function Test Every 3 years (sensitive thyroid stimulating hormone [TSH]).
Cervical Spine X-ray to Rule Out Atlanto-axial Instability Obtain baseline as adult. Recommend repeat if symptomatic, or 30 years from baseline.
Echocardiogram Obtain baseline if no records of cardiac function are available.
General Counseling and Guidance
Prevention Counseling Annually counsel regarding prevention of accidents related to falls, fire/burns, choking and screen for at-risk sexual behavior.
Abuse or Neglect Annually monitor for behavioral signs of abuse and neglect.
Preconception Counseling As appropriate, including genetic counseling, folic acid supplementation, discussion of parenting capability.
Menopause Management At an appropriate age, counsel women on the changes that occur at menopause and their options for the symptom management.
Healthy Lifestyle Annually counsel regarding diet/nutrition, incorporating regular physical activity into daily routines, substance abuse.

**Vaccines are recommended, but may not be covered by MassHealth or Medicare in all cases.

Preparation for an Examination

Many adults can be helped to feel more comfortable at a medical visit if they feel adequately prepared for the event. Family or support staff can be encouraged to introduce unfamiliar items such as a stethoscope or a blood pressure cuff at home to allow the instrument to become more familiar and facilitate cooperation during an exam.

During the exam, it is helpful to prepare patients for procedures by explaining them well or allowing patients with sensory impairments to explore the instruments that are about to be used. Performing simple examinations in an office or quiet waiting room may reduce a person's anxiety.

If someone is particularly anxious or an invasive screening procedure is necessary, the clinician might consider sedation prior to the appointment. In some cases, multiple procedures can be performed while the patient is sedated (dental work, or routine blood work, for example) to reduce the number of times a person is exposed to the risks of sedation.

Communication

First direct your questions to the patient to determine their own perception of their health status and needs. If communication is a problem, clinicians may have to rely on a family member or support staff to provide information relating to signs or symptoms of health concerns. Questions regarding changes in the individual's behavior and adaptive function can bring underlying physical and mental health issues to light.

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The recommendations are based on the Massachusetts Health Quality Partnership (MHQP) Adult Preventive Care Recommendations 2005 and Consensus Guidelines for primary health care of adults with developmental disabilities, Canadian Family Physician, Volume 52 2006.

BENEFITS/HARMS OF IMPLEMENTING THE GUIDELINE RECOMMENDATIONS

POTENTIAL BENEFITS

Appropriate preventive healthcare for adults with intellectual disability (mental retardation)

POTENTIAL HARMS

Not stated

QUALIFYING STATEMENTS

QUALIFYING STATEMENTS

With the presentation of these recommendations, the Advisory Committee does not intend to imply that adults with intellectual and developmental disabilities all have similar health needs or that clinicians should not continue to use their clinical judgment and seek additional consultation when necessary. The Advisory Committee sees these recommendations as one of a number of steps towards ensuring that every adult with intellectual and developmental disabilities receives the most appropriate health care as an individual.

IMPLEMENTATION OF THE GUIDELINE

DESCRIPTION OF IMPLEMENTATION STRATEGY

An implementation strategy was not provided.

IMPLEMENTATION TOOLS

Patient Resources
Quick Reference Guides/Physician Guides

For information about availability, see the "Availability of Companion Documents" and "Patient Resources" fields below.

INSTITUTE OF MEDICINE (IOM) NATIONAL HEALTHCARE QUALITY REPORT CATEGORIES

IOM CARE NEED

Living with Illness
Staying Healthy

IOM DOMAIN

Effectiveness
Patient-centeredness

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Massachusetts Department of Developmental Services. Massachusetts Department of Mental Retardation health screening recommendations. Boston (MA): Massachusetts Department of Developmental Services; 2007. 2 p.

ADAPTATION

The recommendations are based on the Massachusetts Health Quality Partners (MHQP) Adult Preventive Care Recommendations 2005 and Consensus Guidelines for primary health care of adults with developmental disabilities, Canadian Family Physician, Vol.52 2006.

DATE RELEASED

2003 Sep 19 (revised 2007)

GUIDELINE DEVELOPER(S)

Massachusetts Department of Developmental Services - State/Local Government Agency [U.S.]
University of Massachusetts Medical School's Center for Developmental Disabilities Evaluation and Research - Academic Institution

SOURCE(S) OF FUNDING

Massachusetts Department of Developmental Services

GUIDELINE COMMITTEE

Massachusetts Department of Mental Retardation Preventive Health Standards Advisory Committee

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Committee members: Victor Acquista, MD; Norberto Alvarez, MD; Bob Baldor, MD; Allen Crocker, MD; Marc Emmerich, MD; Warren Ferguson, MD; Jim Gleason, PT; Adria Hodas, RN NP; Elizabeth King, RN NP; Leo McKenna, PharmD.; Barbara Pilarcik, RN; Julie Lufkin Purtz, RN NP; Van R. Silka, MD; Carol Walsh RNC, MPH; Susan Weiner, OT

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Massachusetts Department of Mental Retardation, Univ of Massachusetts Medical School's Center for Developmental Disabilities Evaluation and Research. Preventive health recommendations for adults with mental retardation. Boston (MA): Massachusetts Department of Mental Retardation and University of Massachusetts Medical School's Center for Developmental Disabilities Evaluation and Research; 2003 Sep 19. 2 p.

GUIDELINE AVAILABILITY

Print copies: Available from the University of Massachusetts Medical School, Center for Developmental Disabilities Evaluation and Research, 200 Trapelo Road, Waltham, MA 02452; Phone: (781) 642-0283; Fax: (781) 642-0162.

AVAILABILITY OF COMPANION DOCUMENTS

The following is available:

  • Preventive health recommendations for adults with mental retardation. Guidelines for community practitioners. Boston (MA): Massachusetts Department of Mental Retardation and University of Massachusetts Medical School Center for Development Disabilities Evaluation and Research; 2007 Sep. 2 p.

Print copies: Available from the University of Massachusetts Medical School, Center for Developmental Disabilities Evaluation and Research, 200 Trapelo Road, Waltham, MA 02452; Phone: (781) 642-0283; Fax: (781) 642-0162.

PATIENT RESOURCES

The following is available:

  • Massachusetts Department of Mental Retardation annual health screening recommendations. Boston (MA): Massachusetts Department of Mental Retardation and University of Massachusetts Medical School Center for Development Disabilities Evaluation and Research; 2007 Sep 26. 1 p.

Print copies: Available from the University of Massachusetts Medical School, Center for Developmental Disabilities Evaluation and Research, 200 Trapelo Road, Waltham, MA 02452; Phone: (781) 642-0283; Fax: (781) 642-0162.

Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.

NGC STATUS

This summary was prepared by ECRI on January 29, 2004. The information was verified by the guideline developer on February 26, 2004. This summary was updated by ECRI Institute on April 21, 2009. The updated information was verified by the guideline developer on May 12, 2009.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions. Refer to the Center for Developmental Disabilities Education and Research (E.K. Shriver Center for Mental Retardation) for permission to reproduce guidelines.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo